Titusville, NJ, United States of America

Katia Boven

USPTO Granted Patents = 1 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katia Boven: Innovator in HIV Treatment

Introduction

Katia Boven is a notable inventor based in Titusville, NJ (US). She has made significant contributions to the field of medicine, particularly in the treatment of HIV. Her innovative work has led to the development of a patent that addresses critical health challenges.

Latest Patents

Katia Boven holds a patent for "Compositions and methods of treating HIV." This patent focuses on methods for treating subjects infected with HIV using a once-daily regimen. The treatment involves single unit dosage forms that include darunavir, cobicistat, emtricitabine, and a tenofovir prodrug or its salt. This advancement represents a significant step forward in HIV treatment options.

Career Highlights

Throughout her career, Katia has worked with prominent companies in the pharmaceutical industry. She has been associated with Janssen Sciences Ireland UC and Gilead Sciences, Inc. These experiences have allowed her to contribute to groundbreaking research and development in HIV therapies.

Collaborations

Katia has collaborated with esteemed colleagues, including Goedele De Smedt and Regina Driesen. These partnerships have fostered an environment of innovation and have been instrumental in her research endeavors.

Conclusion

Katia Boven's work in HIV treatment exemplifies her dedication to improving healthcare outcomes. Her patent and collaborations highlight her significant impact in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…